Profile
INBS DHR-PB TMO DHR IDXX A
Company Name Intelligent Bio Solutions Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation IDEXX Laboratories, Inc. Agilent Technologies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $14.91M $916.76B $193.40B $146.49B $35.50B $35.11B
Employees 0.05K 79.00K 125.00K 61.00K 11.00K 18.00K
CEO Mr. Harry Simeonidis Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Jonathan J. Mazelsky Mr. Padraig McDonnell
Ratings
INBS DHR-PB TMO DHR IDXX A
Quant Rating Score 2 5 3 3 3 3
Quant Rating Sell Strong Buy Neutral Neutral Neutral Neutral
Trading
INBS DHR-PB TMO DHR IDXX A
Last Close $2.2 $1261.26 $512.65 $204.96 $412.4 $119.85
High 52 $4.59 $1261.26 $624.21 $280.76 $548.53 $154.64
Low 52 $1.07 $1261.26 $509.11 $201.62 $406.92 $119.85
Price vs. 52 Week High -52.07 % 0 % -17.87 % -27 % -24.82 % -22.5 %
Price vs. 52 Week Low 105.61 % 0 % 0.7 % 1.66 % 1.35 % 0 %
Total Return
INBS DHR-PB TMO DHR IDXX A
1 Month Return -7.17 % 0 % -3.75 % 0.67 % -10.3 % -12.17 %
3 Month Return 48.65 % 0 % -2.75 % -12.78 % -4.55 % -13.79 %
6 Month Return 10 % 0 % -16.12 % -25.27 % -17.61 % -12.72 %
9 Month Return 1.85 % 0 % -10.47 % -19.63 % -18.52 % -8.21 %
YTD Return 57.14 % 0 % -1.46 % -10.71 % -0.25 % -10.79 %
1 Year Return -52.07 % 0 % -13.6 % -19.73 % -23.66 % -18.92 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
INBS DHR-PB TMO DHR IDXX A
Dividend Yield Percentage (TTM) - 0.51 % 0.3 % 0.53 % - 0.78 %
Dividend Paid and Capex Coverage Ration (TTM) -61.39 % 3.1 % 4.37 % 3.1 % 7.1 % 3.01 %
Dividend Per Share (TTM) - 1.08 % 1.56 % 1.08 % - 0.96 %
Payout Ratio (TTM) - 19.7 % 9.2 % 19.7 % - 21.92 %
Growth
INBS DHR-PB TMO DHR IDXX A
Asset Growth 33.07 % -1.42 % -8.22 % 10.06 %
Gross Profit Growth 336.41 % 5.81 % 1.23 % 2.02 %
Revenue Growth 147.58 % 0.05 % -0.06 % -4.73 %
Revenue 3 Year -57.19 % 12.79 % -21.41 % 7.64 %
Revenue 5 Year - 75.79 % 29.31 % 36.07 %
Revenue 10 Year - 164.64 % 14.22 % 6.72 %
EBIT Growth 18.36 % 6.97 % -6.52 % 10.22 %
Net Income Growth 4.47 % 5.67 % -18.16 % 3.95 %
Net Income 3 Yeari Growth Per Share 60.68 % -15.42 % -41.24 % 11.3 %
Net Income 5 Yeari Growth Per Share 69.64 % 79.48 % 25.73 % 29.88 %
Net Income 10 Yeari Growth Per Share -544.71 % 248.59 % 42.96 % 196.82 %
Operating Income Growth 18.36 % 6.97 % -6.52 % 10.22 %
Operating Cash Flow Growth (CFG) -29.74 % 3.1 % -6.64 % -1.19 %
Operating 3 Year CFG 76.91 % -6.33 % -22.42 % 23.19 %
Operating 5 Year CFG 62.36 % 82.49 % 64.18 % 85.07 %
Operating 10 Year CFG -747.01 % 244.88 % 69.53 % 181.06 %
EPS Growth 39.7 % 6.76 % -17.86 % 4.98 %
EPS Diluted Growth 39.7 % 7.06 % -17.08 % 5.73 %
Book Value Per Share 39.99 % 7.15 % -7.44 % 1.96 %
Share Holder 3 Year Equity Growth Per Share -83.33 % 25.29 % 6.35 % 14.35 %
Share Holder 5 Year Equity Growth Per Share 139.58 % 74.85 % 58.77 % 34.05 %
Share Holder 10 Year Equity Growth Per Share 130.4 % 151.37 % 101.9 % 27.33 %
Dividend Per Share Growth - 12.64 % -6.53 % 4.47 %
Dividend 3 Year Growth Per Share - 52.23 % 0.35 % 21.3 %
Dividend 5 Year Growth Per Share - 105.55 % 41.45 % 43.54 %
Dividend 10 Year Growth Per Share - 158.83 % 221.34 % 78.17 %
Debt Growth -34.76 % -10.43 % -18.07 % 23.95 %
Free Cash Flow Growth -24.24 % 4.91 % -8.39 % -6.85 %
Updated On 30 Jun 2024 31 Dec 2024 31 Dec 2024 31 Oct 2024
Profitability
INBS DHR-PB TMO DHR IDXX A
Gross Profit Margin TTM 41.07 % 59.5 % 41.49 % 59.5 % 61.08 % 57.75 %
Return on Assets TTM -123.13 % 5.03 % 6.51 % 5.03 % 26.96 % 10.57 %
Return on Equity TTM -142.89 % 7.64 % 13.24 % 7.64 % 55.82 % 20.95 %
Return on Capital Employed TTM -253.18 % 6.87 % 8.73 % 6.87 % 50.78 % 14.73 %
Net Income Per EBT TTM 99.77 % 83.92 % 90.04 % 83.92 % 80 % 84.78 %
EBT Per Ebit TTM 98.88 % 95.54 % 95.98 % 95.54 % 98.21 % 100.34 %
EBIT Per Revenue TTM -357.56 % 20.37 % 17.1 % 20.37 % 28.99 % 22.65 %
Cash Flow To Debt Ratio TTM -1616.99 % 41.79 % 27.71 % 41.79 % 553.68 % 50.46 %
Receivables Turnover TTM 11.39 6.75 5.23 6.75 8.23 4.92
Payables Turnover TTM 1.66 5.52 - 5.52 13.28 5.05
Inventory Turnover TTM 2.55 4.15 5.04 4.15 3.97 2.77
Fixed Asset Turnover TTM 421.11 % 478.46 % 460.77 % 478.46 % 470 % 359.75 %
Asset Turnover TTM 34.91 % 30.79 % 44.06 % 30.79 % 118.34 % 54.83 %
Operating Cash Flow Per Share TTM -2.23 9.25 22.69 9.18 11.29 5.95
Free Cash Flow Per Share TTM -2.27 7.33 19.02 7.27 9.7 4.94
Cash Per Share TTM 49.43 % 287.53 % 1458.12 % 285.1 % 350.25 % 514.74 %
Operating Cash Flow Sales Ratio TTM -333.92 % 28.01 % 20.21 % 28.01 % 23.84 % 25.98 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.63 % 79.19 % 83.85 % 79.19 % 85.91 % 83.03 %
Cash Flow Coverage Ratios TTM -1616.99 % 41.79 % 27.71 % 41.79 % 553.68 % 50.46 %
Price To Free Cash Flows Ratio TTM -1.45 28.62 26.61 27.66 44.48 24.92
Price To Operating Cash Flows Ratio TTM -0.99 22.92 22.6 22.34 38.67 20.67
Price Cash Flow Ratio TTM -0.99 22.92 22.6 22.34 38.67 20.67
Income Statement (TTM)
INBS DHR-PB TMO DHR IDXX A
Revenue $0B $23.88B $42.88B $23.88B $3.9B $6.51B
Gross Profit $0B $14.21B $18.11B $14.21B $2.38B $3.54B
Gross Profit Ratio 45.8% 59.5% 42.23% 59.5% 61.04% 54.3%
EBITDA $-0.01B $4.86B $11.54B $4.86B $1.27B $1.49B
Net Income $-0.01B $3.9B $6.34B $3.9B $0.89B $1.29B
EPS Diluted -6.38 5.29 16.54 5.29 10.69 4.43
Balance Sheet (MRQ)
INBS DHR-PB TMO DHR IDXX A
Long Term Debt $0B $15.5B $29.06B $15.5B $0.1B $3.35B
Total Liabilities $0.01B $27.99B $47.65B $27.99B $1.7B $5.95B
Total Equity $0.01B $49.55B $49.67B $49.55B $1.6B $5.9B
Total Investments $0B $0B $1.56B $0B $0.06B $0.18B
Total Debt $0B $16.01B $31.28B $16.01B $0.27B $3.39B
Total Assets $0.01B $77.54B $97.32B $77.54B $3.29B $11.85B
Cash Flow Statement (TTM)
INBS DHR-PB TMO DHR IDXX A
Net Income $-0.01B $3.9B $6.34B $3.9B $0.89B $1.29B
Inventory $0B $0.15B $0B $0.15B $-0.03B $0.03B
Dividends Paid $0B $-0.77B $-0.58B $-0.77B $0B $-0.27B
Operating Cash Flow $-0.01B $6.69B $8.67B $6.69B $0.93B $1.75B
Capital Expenditure $-0B $-1.39B $-1.4B $-1.39B $-0.13B $-0.38B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 118.93
ACRS Aclaris Therapeutics, Inc. 1.585
ADVB Advanced Biomed Inc. Common Stock 3.5
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 0.0544
AWH Aspira Women's Health Inc. 0.132
BDSX Biodesix, Inc. 0.7747
BIAF bioAffinity Technologies, Inc. 0.3637
BIAFW bioAffinity Technologies, Inc. 0.3148
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 3.5375
BNR Burning Rock Biotech Limited 5.5
CDNA CareDx, Inc 18.11
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 0.79
CNTG Centogene N.V. 0.325
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 170.12
CSTL Castle Biosciences, Inc. 19.03
DGX Quest Diagnostics Incorporated 166.78
ETFs With Exposure to INBS
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 170.65
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 131.85
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 131.86
VEMPX Vanguard Extended Market Index InstlPlus 0 325.39
Unlock